NewsRx

Search our medical news database

Cancer Weekly

Susan Hasty, Publisher

Table of Contents . . . March 29th, 1999

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Cancer Weekly | Other Publications

Colon Cancer (Treatment) - Drug Combination Could Reduce Mortality "Dramatically"

Colorectal Cancer (Therapy) - Regulatory Filing Completed for Oral Cancer Drug

Disease Markers - Report Criticized Finding No Cancer Link in Humans to PCBS

Genetics - Popular Diet Supplement May Be A Cancer Risk

Industry News (Clinical Trials) - ImClone Starts Final Trial of Cancer Drug

Industry News (Joint Venture) - Companies Announce Funding of their Cancer Therapeutics Venture

Industry News (Squamous Cell Carcinoma) - Phase II Cancer Study Starts in Czech Republic

Pediatrics - Surgical Skill, Other Factors Affect Survival Rates in Children with Brain Tumor

Prostate Cancer - Testing Whether Soy Can Reduce Cancer Risk

Prostate Cancer (Funding) - Canada Announces Funding for Prostate Cancer Research

Transplantation Medicine - "Allogeneic Blood Stem Cell Transplantation for Hematologic Malignancies: A Safe Effective Alternative Compared to Allogeneic Bone Marrow Transplantation."

Antiangiogenesis - "Angiostatin 4.5: A Naturally Occurring Human Angiogenesis Inhibitor."

Cancer Gene Therapy - "Gene Therapy for Ovarian Cancer."

Antisense Technology - "Antisense Oligonucleotides to Gastrin Inhibit Growth of Human Pancreatic Cancer."

Bladder Cancer - "Effects of Bacillus Calmette-Guerin and Interferon alpha-2b on Cytokine Production in Human Bladder Cancer Cell Lines."

Colorectal Cancer - "Is Carcino-Embryonic Antigen Useful in the Follow-Up Management of Patients With Colorectal Liver Metastases?."

Glioblastomas (Animal Models) - "Early Induction of Angiogenetic Signals in Gliomas of GFAP-v-src Transgenic Mice."

Melanoma (Therapy) - "Plaque Radiotherapy of Uveal Melanoma With Predominant Ciliary Body Involvement."

Ovarian Cancer - "An Immunoscintigraphic Evaluation of the Engineered Human Monoclonal Antibody (HCTMO1) for Use in the Treatment of Ovarian Carcinoma."

Prostate Cancer - "Prostate Specific Antigen Doubling Time After Radical Prostatectomy: Effect of Neoadjuvant Androgen Deprivation Therapy."

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook